• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有巴斯综合征的严重婴儿型心肌病出现后心脏功能的长期恢复

Extended recovery of cardiac function after severe infantile cardiomyopathy presentation of Barth syndrome.

作者信息

Yester Jessie, Feingold Brian

机构信息

Heart Institute UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania USA.

Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.

出版信息

JIMD Rep. 2021 Dec 28;63(2):114-122. doi: 10.1002/jmd2.12264. eCollection 2022 Mar.

DOI:10.1002/jmd2.12264
PMID:35281665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8898717/
Abstract

Cardiomyopathy is the most common presenting feature of Barth syndrome, often presenting in infancy with severe heart failure and cardiac dysfunction. Historically, affected infants commonly died early after presentation, sometimes before a diagnosis of Barth syndrome was made. With increases in awareness of Barth syndrome and in the care of infants with severe heart failure, survival of children with Barth syndrome and severe heart failure has improved. We describe our experience caring for five unrelated boys with Barth syndrome who presented with severe cardiomyopathy and heart failure prior to age 2 who have had marked improvement with long-term response to medical heart failure therapy.

摘要

心肌病是巴氏综合征最常见的临床表现,常在婴儿期出现严重心力衰竭和心脏功能障碍。从历史上看,受影响的婴儿通常在出现症状后不久死亡,有时在巴氏综合征确诊之前就已死亡。随着对巴氏综合征认识的提高以及对重症心力衰竭婴儿护理水平的提升,患有巴氏综合征和重症心力衰竭的儿童的生存率有所提高。我们描述了我们对五名患有巴氏综合征的不相关男孩的护理经验,他们在2岁之前出现严重心肌病和心力衰竭,通过长期接受心力衰竭药物治疗取得了显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/8898717/9487529de983/JMD2-63-114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/8898717/727b75d453e7/JMD2-63-114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/8898717/9487529de983/JMD2-63-114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/8898717/727b75d453e7/JMD2-63-114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/8898717/9487529de983/JMD2-63-114-g002.jpg

相似文献

1
Extended recovery of cardiac function after severe infantile cardiomyopathy presentation of Barth syndrome.患有巴斯综合征的严重婴儿型心肌病出现后心脏功能的长期恢复
JIMD Rep. 2021 Dec 28;63(2):114-122. doi: 10.1002/jmd2.12264. eCollection 2022 Mar.
2
Differing clinical courses and outcomes in two siblings with Barth syndrome and left ventricular noncompaction.两例巴特综合征并左室心肌致密化不全患儿的临床表现和转归存在差异。
Eur J Pediatr. 2012 Mar;171(3):515-20. doi: 10.1007/s00431-011-1597-0. Epub 2011 Oct 7.
3
Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.家族内新型 TAZ 基因突变的变异性:婴儿期伴有扩张型心肌病和心力衰竭的巴尔综合征,以及他叔祖父的左心室心肌致密化不全。
Mol Genet Metab. 2012 Nov;107(3):428-32. doi: 10.1016/j.ymgme.2012.09.013. Epub 2012 Sep 18.
4
Barth Syndrome with Late-Onset Cardiomyopathy: A Missed Opportunity for Diagnosis.伴有迟发性心肌病的巴斯综合征:一个被错过的诊断机会。
J Pediatr. 2017 Apr;183:196-198. doi: 10.1016/j.jpeds.2016.12.070. Epub 2017 Jan 18.
5
Cardiac and clinical phenotype in Barth syndrome.Barth综合征的心脏及临床表型
Pediatrics. 2006 Aug;118(2):e337-46. doi: 10.1542/peds.2005-2667. Epub 2006 Jul 17.
6
Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.巴特综合征相关性心肌病与心肌葡萄糖氧化减少有关。
Am J Physiol Heart Circ Physiol. 2021 Jun 1;320(6):H2255-H2269. doi: 10.1152/ajpheart.00873.2020. Epub 2021 Apr 30.
7
Quality of life in Barth syndrome.巴特综合征患者的生活质量
Ther Adv Rare Dis. 2022 Jun 11;3:26330040221093743. doi: 10.1177/26330040221093743. eCollection 2022 Jan-Dec.
8
Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.Elamipretide 治疗 Barth 综合征心肌病:逐渐重建失败的电网。
Heart Fail Rev. 2022 Sep;27(5):1911-1923. doi: 10.1007/s10741-021-10177-8. Epub 2021 Oct 8.
9
AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome.腺相关病毒基因治疗可预防和逆转巴特综合征小鼠模型的心力衰竭。
Circ Res. 2020 Apr 10;126(8):1024-1039. doi: 10.1161/CIRCRESAHA.119.315956. Epub 2020 Mar 9.
10
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.巴特综合征心肌病:以线粒体为靶点的埃拉米肽治疗。
Heart Fail Rev. 2021 Mar;26(2):237-253. doi: 10.1007/s10741-020-10031-3. Epub 2020 Oct 1.

引用本文的文献

1
Challenges in medication titration in children with heart failure.儿童心力衰竭药物滴定的挑战。
JHLT Open. 2025 Aug 5;10:100358. doi: 10.1016/j.jhlto.2025.100358. eCollection 2025 Nov.

本文引用的文献

1
Favorable outcomes after heart transplantation in Barth syndrome.巴德-希利综合征心脏移植后结局良好。
J Heart Lung Transplant. 2021 Oct;40(10):1191-1198. doi: 10.1016/j.healun.2021.06.017. Epub 2021 Jul 10.
2
Increased Reactive Oxygen Species-Mediated Ca/Calmodulin-Dependent Protein Kinase II Activation Contributes to Calcium Handling Abnormalities and Impaired Contraction in Barth Syndrome.活性氧介导的钙/钙调蛋白依赖性蛋白激酶 II 激活增加导致 Barth 综合征的钙处理异常和收缩功能障碍。
Circulation. 2021 May 11;143(19):1894-1911. doi: 10.1161/CIRCULATIONAHA.120.048698. Epub 2021 Apr 1.
3
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
《2017年美国心脏病学会(ACC)心力衰竭治疗优化专家共识决策路径2021年更新:关于射血分数降低的心力衰竭的10个关键问题解答:美国心脏病学会解决方案集监督委员会报告》
J Am Coll Cardiol. 2021 Feb 16;77(6):772-810. doi: 10.1016/j.jacc.2020.11.022. Epub 2021 Jan 11.
4
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.巴特综合征心肌病:以线粒体为靶点的埃拉米肽治疗。
Heart Fail Rev. 2021 Mar;26(2):237-253. doi: 10.1007/s10741-020-10031-3. Epub 2020 Oct 1.
5
AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome.腺相关病毒基因治疗可预防和逆转巴特综合征小鼠模型的心力衰竭。
Circ Res. 2020 Apr 10;126(8):1024-1039. doi: 10.1161/CIRCRESAHA.119.315956. Epub 2020 Mar 9.
6
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match.国际心脏和肺移植协会国际胸科器官移植登记处:2019年第二十二份小儿心脏移植报告;重点主题:供体与受体大小匹配
J Heart Lung Transplant. 2019 Oct;38(10):1028-1041. doi: 10.1016/j.healun.2019.08.002. Epub 2019 Aug 10.
7
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.恢复性扩张型心肌病患者停止心力衰竭的药物治疗(TRED-HF):一项开放标签、先导、随机试验。
Lancet. 2019 Jan 5;393(10166):61-73. doi: 10.1016/S0140-6736(18)32484-X. Epub 2018 Nov 11.
8
Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy.扩张型心肌病患儿未经心脏移植的生存率
J Am Coll Cardiol. 2017 Nov 28;70(21):2663-2673. doi: 10.1016/j.jacc.2017.09.1089.
9
The Pediatric Heart Failure Workforce: An International, Multicenter Survey.儿科心力衰竭专业人员:一项国际多中心调查
Pediatr Cardiol. 2018 Feb;39(2):307-314. doi: 10.1007/s00246-017-1756-9. Epub 2017 Nov 17.
10
Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study).沙库巴曲缬沙坦(LCZ696)与依那普利治疗因左心室收缩功能障碍导致心力衰竭的儿科患者的比较研究(全景-心力衰竭研究)。
Am Heart J. 2017 Nov;193:23-34. doi: 10.1016/j.ahj.2017.07.006. Epub 2017 Jul 17.